SCHEMBL1783223

SCHEMBL1783223

CC(=O)Nc1nc2c(s1)C(O)=C(C(=O)c1ccc(F)nc1)CC2

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
OGA O60502 4/20 0.42
PIK3CG P48736 7/20 0.39
PIK3CD O00329 2/20 0.39
PIK3CA P42336 2/20 0.39
PIK3CB P42338 2/20 0.39
BDKRB1 P46663 1/20 0.37
DYRK1A Q13627 3/20 0.35
PDPK1 O15530 1/20 0.35
LMNA P02545 2/20 0.35
GAA P10253 2/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 1/20 0.35
ALDH1A1 P00352 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
RAB9A P51151 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1117951 0.90 TSHR (0.40) OGALMNAGAAMAPTHPGD
SCHEMBL1781491 0.88 PIK3CG (0.42) PIK3CGPIK3CDPIK3CAPIK3CBLMNA
SCHEMBL1781217 0.88 PIK3CG (0.43) PIK3CGPIK3CDPIK3CAPIK3CBDYRK1A
SCHEMBL13690398 0.88 PIK3CA (0.43) OGAPIK3CGPIK3CDPIK3CAPIK3CB
SCHEMBL1118042 0.87 PIK3CG (0.38) OGAPIK3CGPIK3CDPIK3CAPIK3CB
SCHEMBL1784359 0.87 HCAR3 (0.40) OGAPIK3CGPIK3CDPIK3CAPIK3CB
SCHEMBL1117949 0.86 OGA (0.33) OGALMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL1782049 0.86 PIK3CG (0.38) OGAPIK3CGPIK3CDPIK3CAPIK3CB
SCHEMBL1782298 0.86 PIK3CG (0.50) OGAPIK3CGPIK3CDPIK3CAPIK3CB
SCHEMBL1781135 0.86 PIK3CG (0.39) OGAPIK3CGPIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304556-B2 Thiazolyl-dihydro-indazoles BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-11-06 US disclosed
US-8304556-B2 Thiazolyl-dihydro-indazoles BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-11-06 US disclosed
US-20120108567-A1 Thiazolyl-Dihydro-Indazoles BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-05-03 US disclosed
US-20120108567-A1 Thiazolyl-Dihydro-Indazoles BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-05-03 US disclosed
US-20110118208-A1 Thiazolyl-Dihydro-Indazoles BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-05-19 US disclosed
US-20110118208-A1 Thiazolyl-Dihydro-Indazoles BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-05-19 US disclosed
CN-102015728-A Thiazolyl-dihydro-indazoles BOEHRINGER INGELHEIM INT 2011-04-13 CN disclosed
WO-2009112565-A1 THIAZOLYL-DIHYDRO-INDAZOLES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-09-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108567-A1 Thiazolyl-Dihydro-Indazoles MKI67, CYP11B1, IGF1R OGA 4252/4885PIK3CG 4280/4885PIK3CD 3523/4885
US-20110118208-A1 Thiazolyl-Dihydro-Indazoles MKI67, CYP11B1, IGF1R OGA 4252/4885PIK3CG 4280/4885PIK3CD 3523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.